The Quantellect read.As of Nov 19, 2026, 7 active firms cover LifeMD Inc: 7 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $8.00 to $10.00, so the covering firms are broadly aligned. The average target of $9.00 sits 431% above the current $1.70. The rating mix has stayed broadly stable, with Buy-side ratings easing from 8 to 7 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.07 next quarter toward $0.15 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS7 active firms
Buy
Strong Buy00%
Buy7100%
Neutral00%
Sell00%
Strong Sell00%
Based on 7 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$9.00
+431.0% upside
Average target across 4 active firms as of Nov 19, 2026 vs $1.70 current
Highest Target$10.00
Average Target$9.00
Lowest Target$8.00
Detailed analyst forecasts for LFMD
Showing 1–4 of 4 named analysts shown · 7 active firms in the rating projection
As of Nov 19, 2026, 7 of 7 active firms rate LFMD a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
LFMD EPS & revenue forecast
EPS · NEXT QUARTER
$0.07
Range $0.07 – $0.07 · 1 analysts · -146% YoY
Next period, 1 analysts expect LifeMD Inc to earn $0.07 a share (range $0.07 – $0.07), versus $-0.15 a year earlier. Full-year consensus is $-0.34, growing to $0.15 the year after.
REVENUE · NEXT QUARTER
$54.7M
Range $50.7M – $62.0M · 1 analysts · +9% YoY
Revenue is expected to reach $54.7M (range $50.7M – $62.0M), +9.1% year-over-year. Full-year consensus is $189.2M, rising to $235.6M next year.
Top analysts covering LifeMD Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on LFMD.
#1
Sarah James
Cantor Fitzgerald · Rank #159
Buy
$15.00+785.0% to target
Overall win rate
37%
+ Follow
#2
Ryan Meyers
Lake Street · Rank #340
Buy
$5.00+195.0% to target
Overall win rate
39%
+ Follow
#3
Yi Chen
HC Wainwright & Co. · Rank #350
Buy
$9.00+431.0% to target
Overall win rate
34%
+ Follow
#4
Scott Schoenhaus
Keybanc · Rank #540
Buy
$5.00+195.0% to target
Overall win rate
30%
+ Follow
#5
David Larsen
BTIG
Buy
$9.00+431.0% to target
Coverage
—
+ Follow
LFMD stock forecast FAQ
What is LFMD's average 12-month price target?+
The 4 active firms with a live target average $9.00 for LifeMD Inc over the next 12 months, ranging from a $10.00 high to a $8.00 low, as of Nov 19, 2026.
Is LFMD stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 7 active firms as of Nov 19, 2026, 7 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for LFMD?+
The Street-high target is $10.00 (Freedom Capital Markets), and the Street-low is $8.00 (B. Riley Securities). The average of all 4 active-firm targets is $9.00.
How many active Wall Street firms cover LFMD?+
7 active firms have a recognized rating on LifeMD Inc as of Nov 19, 2026, and 4 active firms carry a live 12-month price target.
Who is the most accurate analyst covering LFMD?+
Among analysts who currently cover LFMD, Sarah James of Cantor Fitzgerald has the strongest overall Quantellect track record (Rank #159). Their current call is Buy with a $15.00 target.
What is LifeMD Inc's projected EPS for next quarter?+
The consensus estimate is $0.07 per share (range $0.07 – $0.07) across 1 analysts. Full-year EPS is projected at $-0.34, rising to $0.15 the following year.
How much revenue is LifeMD Inc expected to report next quarter?+
Consensus revenue is $54.7M (range $50.7M – $62.0M). Full-year revenue is projected at $189.2M, growing to $235.6M next year.
Have analysts been upgrading or downgrading LFMD lately?+
As of Nov 19, 2026, 7 of 7 active firms rate LFMD a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their LFMD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.